Unsupervised analysis of electronic nose data identifies patient clusters in fibrosing interstitial lung disease

I. van der Sar (Rotterdam, Netherlands), C. Moor (Rotterdam, Netherlands), M. Luijendijk (Rotterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), M. Wijsenbeek (Rotterdam, Netherlands)

Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Session: News in treatment and diagnosis of idiopathic interstitial pneumonia
Session type: E-poster
Number: 475

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. van der Sar (Rotterdam, Netherlands), C. Moor (Rotterdam, Netherlands), M. Luijendijk (Rotterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Aerts (Rotterdam, Netherlands), M. Wijsenbeek (Rotterdam, Netherlands). Unsupervised analysis of electronic nose data identifies patient clusters in fibrosing interstitial lung disease. 475

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Preliminary data on the acoustic frequency analysis of cough in patients with interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 528s
Year: 2001

Validation of the artificial intelligence software to detect chronic fibrosing interstitial lung diseases in chest X-ray
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Year: 2021



Clinical and molecular analysis of lung cancer associated with fibrosing and diffuse interstitial lung disease.
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



Transbronchial pulmonary criobiopsy’s relevance in the diagnostic approach of diffuse pulmonary diseases- Data analysis of the initial learning curve
Source: International Congress 2016 – IPF clinical
Year: 2016



Gene-set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010


Volumetric texture analysis in the characterisation of interstitial lung diseases in lung transplant patients.
Source: International Congress 2017 – Various imaging modalities for different lung diseases
Year: 2017

Unsupervised phenotypic clustering for determining clinical status in children with cystic fibrosis
Source: Eur Respir J, 58 (2) 2002881; 10.1183/13993003.02881-2020
Year: 2021



Combined pulmonary fibrosis and emphysema. Descriptive analysis from a specialized clinic of interstitial lung disease
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011

Clusters, classification and epidemiology of interstitial lung diseases: concepts, methods and critical reflections
Source: Eur Respir J 2001; 18: 101S-106S
Year: 2001



BALF proteomic analysis in polymyositis/dermatomyositis patients with interstitial lung disease
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015


Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Clinical management of the idiopathic interstitial pneumonias: an example of an integrated approach to interstitial lung diseases
Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias
Year: 2006


Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Time as the fourth dimension of radiology: a patient with diffuse lung disease (interstitial lung disease)
Source: International Congress 2016 – GR2 Radiology
Year: 2016


Should we perform surgical lung biopsy when transbronchial cryobiopsy provides unclassifiable interstitial pneumonitis in a patient with diffuse interstitial lung disease?
Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity
Year: 2020


Estimating long-term survival in progressive fibrosing interstitial lung disease (PF-ILD) other than IPF using matched IPF data
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis
Source: International Congress 2019 – Medical education
Year: 2019

Immunophenotyping and genic re-arrangement analysis in lymphocytic/lymphoproliferative disorders of the lungs
Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease
Year: 2007



Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015